Nuvigil has been declined for approval by the U.S. Health regulators after some questionable data in making the said Cephalon sleep disorder drug. Nuvigil is a successor to Provigil and was introduced last June. Cephalon received a response letter of denial to approve the drug for jet lag this time.
According to the Centers for Disease Control and Prevention Agency in U.S, Jet Lag is a condition marked by a disrupted sleep cycle, headaches, or an upset stomach. Initially, The FDA had given an expedited six month evaluation for jet lag as part of a priority review program for novel medicines.
(Source) EYugoslavia
Also see other interesting tags at SleepZine: centers for disease control, centers for disease control and prevention, cephalon, fda, headaches, health regulators, jet lag, novel medicines, nuvigil, prevention agency, provigil, questionable data, response letter, sleep, sleep-disorder, upset stomach
More similar categories at Sleepzine: Sleep Disorders, Sleeping Pills.
